EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study

Elango Gayathri, Parvathareddy Sowmya, Kumaravelu Punnagai, Veeraraghavan Mahalakshmi

Indian Journal of Dermatology, Venereology and Leprology · 2023

DOI: 10.25259/ijdvl_333_2021 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, 2023. Verfasst von Elango Gayathri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dhanalakshmi Srinivasan Medical College, Perambalur, Tamil Nadu, India. Hauptthemen laut MEDLINE: Histamine H1 Antagonists, Non-Sedating, Urticaria, Chronic Urticaria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urticaria is a common skin disease which often causes impairment in the quality of life. The ideal drug for chronic urticaria would have antihistaminic and anti-inflammatory actions. Bepotastine besilate is a recently approved novel anti-allergic agent with multiple mechanisms of action; levocetirizine is a potent and selective second-generation H 1 receptor antagonist used in the treatment of urticaria.

Aim

To compare the efficacy and safety of bepotastine besilate versus levocetirizine in patients with chronic spontaneous urticaria.

Methods

The study design is a randomised, open-label, parallel-group, prospective interventional study. The study subjects were randomly assigned to either of the two groups a and b, each group had 50 patients with chronic urticaria. Statistical analyses were performed using (SPSS, version 18) for all the variables. Chi-square test was used for comparison between categorical variables. An unpaired student’s t -test was done for quantitative variables.

Results

There was a significant decrease in mean urticaria activity score ( P < 0.001), chronic urticaria quality of life ( P < 0.001) and clinical global improvement ( P < 0.001) in both the treatment groups but this improvement was higher in the bepotastine than in the levocetirizine group. There was no significant difference in the mean of absolute eosinophil count, C-reactive protein, aspartate transaminase, alanine transaminase from baseline to 4th week between the two study groups. Visual analogue scale showed statistically significant improvement from baseline to 4th week ( P < 0.001) of follow-up but this increase was higher in levocetirizine group (0.64-4.24) than in bepotastine group (0.56-2.56)

Limitations

Blinding was not done. To assess the efficacy and safety of bepotastine, a larger study can be planned.

Conclusion

This study found that bepotastine is superior to levocetirizine and showed a statistically significant reduction in mean urticaria activity score 7, improved quality of life and clinical global improvement in patients with urticaria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histamine H1 Antagonists, Non-SedatingUrticariaChronic UrticariaHumansProspective StudiesQuality of LifeCetirizinePiperidinesPyridines

Stichwörter der Autor:innen

Urticariabepotastinelevocetirizineurticaria activity score 7

Substanzen

CetirizineHistamine H1 Antagonists, Non-Sedatinglevocetirizinebepotastine besilatePiperidinesPyridines

Autor:innen und Institutionen

  • Department of Pharmacology, Dhanalakshmi Srinivasan Medical College, Perambalur, Tamil Nadu, India.
  • Department of Pharmacology, Sri Ramachandra Medical College & Research Institute, Chennai, Tamil Nadu, India.

Zitieren

APA

Gayathri, E., Sowmya, P., Punnagai, K., & Mahalakshmi, V. (2023). Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study. Indian Journal of Dermatology, Venereology and Leprology. https://doi.org/10.25259/ijdvl_333_2021

Vancouver

Gayathri E, Sowmya P, Punnagai K, Mahalakshmi V. Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study. Indian Journal of Dermatology, Venereology and Leprology. 2023. doi:10.25259/ijdvl_333_2021

BibTeX
@article{Gayathri2023,
  author = {Gayathri, Elango and Sowmya, Parvathareddy and Punnagai, Kumaravelu and Mahalakshmi, Veeraraghavan},
  title = {Comparative study on the efficacy and safety of bepotastine besilate versus levocetirizine in chronic spontaneous urticaria: A randomised, open-label, parallel study},
  journal = {Indian Journal of Dermatology, Venereology and Leprology},
  year = {2023},
  doi = {10.25259/ijdvl_333_2021}
}
Kostenlos starten →